Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.
Press releases published on April 10, 2025
Crinetics Pharmaceuticals Announces April 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 10, 2025
SAN DIEGO, April 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on April 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of …
Harvard Bioscience Announces CFO Transition
GlobeNewswire
·
April 10, 2025
HOLLISTON, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the resignation of Jennifer Cote, the Company’s Chief Financial Officer and Treasurer. Ms. Cote’s resignation will be effective …
Arcutis Announces Chief Financial Officer Transition
GlobeNewswire
·
April 10, 2025
WESTLAKE VILLAGE, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that David Topper, …
BrightSpring Health Services, Inc. to Announce First Quarter 2025 Financial Results on May 2, 2025
GlobeNewswire
·
April 10, 2025
LOUISVILLE, Ky., April 10, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its first quarter 2025 financial results on Friday, May 2, 2025, prior to the …
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 10, 2025
DUBLIN, April 10, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel’s Board of Directors approved the grant of non- …
Protara Therapeutics to Present Interim Analysis from the Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the American Urological Association Annual Meeting
GlobeNewswire
·
April 10, 2025
NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that two presentations and a panel …
Folia Health Expands Its Rare Renal Disease Research with a New C3G Study to Assess Real-World Disease Impact
GlobeNewswire
·
April 10, 2025
BOSTON, April 10, 2025 (GLOBE NEWSWIRE) -- Folia Health launches enrollment for an innovative, at-home real-world evidence initiative for individuals with C3 glomerulopathy (C3G). Designed in partnership with C3G clinicians and patients, this study uses …
PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas
GlobeNewswire
·
April 10, 2025
SAN JOSE, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company, whose mission is to revolutionize BPH treatment globally, announced today it will host an in-person investor …
Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) to be Presented at the National Kidney Foundation Spring Clinical Meetings
GlobeNewswire
·
April 10, 2025
WALTHAM, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …
Sanara MedTech to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025
GlobeNewswire
·
April 10, 2025
FORT WORTH, TX, April 10, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical …
Theriva Biologics anuncia la presentación de los datos del ensayo clínico de fase 1b/2a de SYN-004 (ribaxamasa) en receptores de trasplantes alogénicos de células hematopoyéticas
GlobeNewswire
·
April 10, 2025
ROCKVILLE, Maryland, April 10, 2025 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), («Theriva» o la «Empresa»), una empresa diversificada de fase clínica que desarrolla terapias diseñadas para tratar el cáncer y enfermedades relacionadas en …
Empowering Women, Strengthening Canada: Three Policy Priorities for Advancing Women’s Health in Canada
GlobeNewswire
·
April 10, 2025
TORONTO, April 10, 2025 (GLOBE NEWSWIRE) -- At Women’s Health Collective Canada (WHCC), we envision a future where every woman in Canada receives the high-quality care she deserves. Rooted in our mission to be Canada’s foremost authority on women’s health …
Global Prefilled Syringes Market to Cross USD 28 Billion by 2032 | DelveInsight
GlobeNewswire
·
April 10, 2025
New York, USA, April 10, 2025 (GLOBE NEWSWIRE) -- Global Prefilled Syringes Market to Cross USD 28 Billion by 2032 | DelveInsight The global market for prefilled syringes is expanding, driven by the rising prevalence of chronic illnesses, greater use of …
The Guardian Group Announces its STATE OF QME REPORTING 2025: Stakeholder Survey Report
GlobeNewswire
·
April 10, 2025
Santa Ana, Ca, April 10, 2025 (GLOBE NEWSWIRE) -- The Guardian Group, LCC, a leading firm in the medical-legal industry, today released: “STATE OF QME REPORTING 2025 " its annual report that explores the utility and effectiveness of QME Reports throughout …
Okeiro lève 10 millions d’euros pour accélérer le développement de sa plateforme de médecine de précision dans la transplantation et les maladies chroniques
GlobeNewswire
·
April 10, 2025
Okeiro lève 10 millions d’euros pour accélérer le développement de sa plateforme de médecine de précision dans la transplantation et les maladies chroniques Paris, 10 avril 2025 – Okeiro1, société spécialisée dans la médecine de précision appliquée à la …
Arkos Health Hosts "WILD ABOUT WELLNESS" Health Fair at Phoenix Zoo
GlobeNewswire
·
April 10, 2025
Phoenix, AZ, April 10, 2025 (GLOBE NEWSWIRE) -- Arkos Health is thrilled to announce the WILD ABOUT WELLNESS health fair, an exclusive event for Arkos Health members enrolled in Arizona Complete Health plans, including Wellcare by Allwell, Complete Care …
Lipozem Reviews (Customer Reports): I TRIED IT, Tracked It, and Exposed the Good, Bad & Shocking Truth!
GlobeNewswire
·
April 10, 2025
LAKELAND, Fla., April 10, 2025 (GLOBE NEWSWIRE) -- Lipozem was not even on my radar when I first set out to tackle the stubborn weight that had clung to me for years. I’d dabbled in countless diets—strict low-carb regimens, juice cleanses, punishing …
Nature Communications Publishes Pivotal Data From Albatroz Therapeutics Demonstrating That Inhibiting Calnexin Alleviates Arthritis Symptoms and May Reverse Disease Progression
GlobeNewswire
·
April 10, 2025
Study uncovers insights about the progression of arthritis, the leading cause of disability which affects 1 in 5 adults and more than half of seniors age 75+ Publication demonstrates a novel therapeutic approach targeting Calnexin that may prevent …
Nextech and Ocuco Announce Strategic Partnership to Revolutionize Optical Solutions
GlobeNewswire
·
April 10, 2025
Tampa, Fla., April 10, 2025 (GLOBE NEWSWIRE) -- Nextech, a leading technology provider for specialty medical and wellness practices and Ocuco, a global leader in optical software solutions, are excited to announce a strategic partnership to deliver an …
Eleos Expands Executive Leadership Bench Following Series C Fundraise
GlobeNewswire
·
April 10, 2025
BOSTON and TEL AVIV, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- Eleos, the leader in AI for behavioral health, today announced the appointment of a deep bench of industry-leading executive talent to support the company through its next phase of growth. …